Celldex Therapeutics Inc
Biotechnology
Healthcare
CLDX
66.38 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
24.87
52 week high
44.16
high
24.95
52 week low
0.00
low
24.11
growth
-41.25 %
previous Close
24.86
P/E ratio
market cap
1.47 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
7740.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top